Associate Professor, Medicine, University of Alabama School of Medicine
Rheumatology
Dr. Barri J. Fessler, MD
|
|
Give Review
Barri J. Fessler, MD is an expert in the field of Rheumatology. She went to medical school at Stony Brook University School of Medicine. She received 5 awards: "Regional Top Doctor", "Meaningful Use Stage 1 Certification", "Fellow (FACP)", "Fellow (FACR)" and "Fellow". Barri Fessler is a published physician. She published 99 publications, including: 'The pharmacokinetics and pharmacodynamics of fludarabine in rheumatoid arthritis.' Dr. Barri J. Fessler accepts Medicare payments and is listed with Medicare.gov.
Publications
- Disrupted Sleep is Associated with Altered Pain Processing by Sex and Ethnicity in Knee OsteoArthritis.
- Anti-C1q antibodies in Systemic lupus erythematosus.
- A Cross-Sectional Examination of Vitamin D, Obesity, and Measures of Pain and Function in Middle-Aged and Older Adults with Knee OsteoArthritis.
- Antinuclear antibody-negative Systemic sclerosis.
- Rituximab Versus Cyclophosphamide for ANCA-Associated Vasculitis with Renal Involvement.
- Temporal summation of pain as a prospective predictor of clinical pain severity in adults aged 45 years and older with knee osteoArthritis: ethnic differences.
- Factors associated with damage accrual in patients with Systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Incep...
- American College of Rheumatology Criteria at Inception, and Accrual over 5 Years in the SLICC Inception Cohort.
- Multicriteria decision analysis methods with 1000Minds for developing Systemic sclerosis classification criteria.
- Racial and ethnic differences in older adults with knee osteoArthritis.
- Immunochip analysis identifies multiple susceptibility Loci for Systemic sclerosis.
- Pain Hypervigilance is Associated with Greater Clinical Pain Severity and Enhanced Experimental Pain Sensitivity Among Adults with Symptomatic Knee OsteoArthritis.
- Age and race effects on Pain sensitivity and modulation among middle-aged and older adults.
- Experimental pain sensitivity differs as a function of clinical pain severity in symptomatic knee osteoArthritis.
- Serum proteins reflecting inflammation, injury and repair as biomarkers of Disease activity in ANCA-associated vasculitis.
- Efficacy of remission-induction regimens for ANCA-associated Vasculitis.
- Psychological profiles and pain characteristics of older adults with knee osteoArthritis.
- Update on Vasculitis.
- Circulating markers of vascular injury and angiogenesis in ANCA-associated Vasculitis.
- ANCA-associated Vasculitis. Preface.
- A multicenter, randomized, double-blind, placebo-controlled trial of oral type I collagen treatment in patients with diffuse cutaneous Systemic sclerosis: I. oral type...
- Systemic lupus erythematosus in a multiethnic US cohort (LUMINA L II): relationship between vascular events and the use of hormone replacement therapy in postmenopausa...
- Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXI. Disease activity, damage accrual, and vascular events in pre- and postmenopausal women.
- Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXII. Predictors of time to the occurrence of initial damage.
- Effects of prasterone on Disease activity and symptoms in women with active systemic lupus erythematosus.
- Systemic lupus erythematosus in three ethnic groups. XIX. Natural history of the accrual of the American College of Rheumatology criteria prior to the occurrence of cr...
- Systemic lupus erythematosus in a multiethnic lupus cohort (LUMINA). XVII. Predictors of self-reported health-related quality of life early in the Disease course.
- Systemic lupus erythematosus in three ethnic groups. XIV. Poverty, wealth, and their influence on Disease activity.
- Early clinical manifestations, Disease activity and damage of systemic lupus erythematosus among two distinct US Hispanic subpopulations.
- Systemic lupus erythematosus in three ethnic groups. XX. Damage as a predictor of further damage.
- Can the weighted criteria improve our ability to capture a larger number of Lupus patients into observational and interventional studies? A comparison with the America...
- Systemic lupus erythematosus in three ethnic groups: XV. Prevalence and correlates of Fibromyalgia.
- Open label trial of tamoxifen in scleroderma.
- Systemic lupus erythematosus and gouty Arthritis: an uncommon association.
- SLE in three ethnic groups XIII. the ''weighted'' criteria as predictors of damage.
- High dose versus low dose fludarabine in the treatment of patients with severe refractory rheumatoid Arthritis.
- Thrombotic syndromes and autoimmune Diseases.
- Glucocorticoids modulate CD28 mediated pathways for interleukin 2 production in human T Cells: evidence for posttranscriptional regulation.
- Management of Lupus nephritis.
- Calcium/calmodulin-dependent protein kinase II downregulates both calcineurin and protein kinase C-mediated pathways for cytokine gene transcription in human T Cells.
- Systemic lupus erythematosus: emerging concepts. Part 2: Dermatologic and joint Disease, the antiphospholipid antibody syndrome, pregnancy and hormonal therapy, morbid...
- Systemic lupus erythematosus: emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic Disease.
- Severe major organ involvement in Systemic lupus erythematosus. Diagnosis and management.
- Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis.
- Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual.
- Sociocultural issues in clinical research.
- Systemic lupus erythematosus in three ethnic groups. VII correction of VIII. Predictors of early mortality in the LUMINA cohort. LUMINA Study Group.
- Systemic lupus erythematosus in three ethnic groups. VIII. Lack of association of glutathione S-transferase null alleles with Disease manifestations.
- Cutting edge: a role for B lymphocyte stimulator in Systemic lupus erythematosus.
- Alveolar hemorrhage in Systemic lupus erythematosus: presentation and management.
- Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXVIII. Factors predictive of thrombotic events.
- Systemic lupus erythematosus in a multi-ethnic cohort (LUMINA) XXXII: corrected contributions of admixture and socioeconomic status to renal involvement.
- Systemic lupus erythematosus in a multiethnic U.S. cohort (LUMINA) XXVII: factors predictive of a decline to low levels of Disease activity.
- Ethnic disparities in health and Disease: the need to account for ancestral admixture when estimating the genetic contribution to both (LUMINA XXVI).
- Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIV. Cytotoxic treatment is an additional risk factor for the development of symptomatic osteonecros...
- Relationship between adherence to study and clinic visits in Systemic lupus erythematosus patients: data from the LUMINA cohort.
- Systemic lupus erythematosus in a multiethnic US Cohort (LUMINA). XXX: association between C-reactive protein (CRP) gene polymorphisms and vascular events.
- Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high Disease activity over time.
- Predictors of post-partum damage accrual in Systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (XXXVIII).
- Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XL II: factors predictive of new or worsening proteinuria.
- Proposed response criteria for neurocognitive impairment in Systemic lupus erythematosus clinical trials.
- Systemic lupus erythematosus in a multiethnic US Cohort LUMINA XLVIII: factors predictive of pulmonary damage.
- Systemic lupus erythematosus in a multiethnic US cohort LUMINA LI: anaemia as a predictor of Disease activity and damage accrual.
- Adolescent onset of lupus results in more aggressive Disease and worse outcomes: results of a nested matched case-control study within LUMINA, a multiethnic US cohort ...
- Adverse pregnancy outcomes in women with Systemic lupus erythematosus from a multiethnic US cohort: LUMINA (LVI) [corrected].
- Autoantibodies as biomarkers for the prediction of neuropsychiatric events in Systemic lupus erythematosus.
- SF-36 summary and subscale scores are reliable outcomes of neuropsychiatric events in Systemic lupus erythematosus.
- 5-lipoxygenase-inhibitors from medicinal plants.
- New Chlorine-Containing Sesquiterpene Lactones from Chrysanthemum parthenium.
- The pharmacokinetics and pharmacodynamics of fludarabine in rheumatoid Arthritis.
- [In vitro 5-lipoxygenase inhibition by Elipta alba extracts and the coumestan derivative wedelolactone].
- New chromone, coumarin, and coumestan derivatives from Mutisia acuminata var. hirsuta.
- Effects of garlic constituents on arachidonate metabolism.
- Anti-asthmatic effects of onions. Alk(en)ylsulfinothioic acid alk(en)yl-esters inhibit histamine release, leukotriene and thromboxane biosynthesis in vitro and counter...
- Wedelolactone and coumestan derivatives as new antihepatotoxic and antiphlogistic principles.
- [Metabolic Syndrome and type II diabetes].
- [Alzheimer''s Disease: irreparable damage in the brain?].
- [Color-coded duplex ultrasound of lower leg arteries--image reliability with reference to Fontaine stages].
- Systemic lupus erythematosus in three ethnic groups. XI. Sources of discrepancy in perception of Disease activity: a comparison of physician and patient visual analog ...
- A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for Giant cell arteritis.
- Systemic lupus erythematosus in three ethnic groups. X. Measuring cognitive impairment with the cognitive symptoms inventory.
- Infectious Diseases in systemic lupus erythematosus: risk factors, management and prophylaxis.
- Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with Systemic sc...
- Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events.
- Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXIX. Elevation of erythrocyte sedimentation rate is associated with Disease activity and damage accrual.
- Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXV. Smoking, older age, Disease activity, lupus anticoagulant, and glucocorticoid dose as risk facto...
- Persistent cryoglobulinemic Vasculitis following successful treatment of hepatitis C virus.
- Time to renal Disease and end-stage renal Disease in PROFILE: a multiethnic lupus cohort.
- Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, Disease activity, an...
- Systemic lupus erythematosus in three ethnic groups: XVI. Association of hydroxychloroquine use with reduced risk of damage accrual.
- Systemic lupus erythematosus in three ethnic groups. XVIII. Factors predictive of poor compliance with study visits.
- Cyclophosphamide versus placebo in scleroderma lung Disease.
- Systemic lupus erythematosus in a multiethnic US cohort: XXXIV. Deficient mannose-binding lectin exon 1 polymorphisms are associated with cerebrovascular but not with ...
- Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung Disease: results from the scleroderma lung study.
- Effect of hydroxychloroquine on the survival of patients with Systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L).
- Bosentan treatment of digital ulcers related to Systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial.
- Systemic lupus erythematosus in a multiethnic US cohort, LUMINA (XLIX): preliminary evaluation of the impact of statins on Disease activity.
- Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung Disease.
Schools
Stony Brook Univ Health Sciences Center School Of Medicine
Graduate Hospital
University Hospital SUNY Stony Brook
Procedures Preformed
- Joint Drainage
- Steroid Injection
Conditions Treated
- Ankylosing Spondylitis
- Arthritis
- Behçet's Disease
- Bursitis
- View All
Doctors Specialties
- Rheumatology
Accepted Insurances
Awards
- Regional Top Doctor
- Meaningful Use Stage 1 Certification
- Fellow (FACP)
- Fellow (FACR)
- Fellow
Education
-
SUNY Stony Brook University Hospital & Medical Center -
Stony Brook University School of Medicine
Hospital
-
Birmingham Veterans Affairs Medical Center
Drug Facts
| NPI NUMBER | 1164466835 | |
| NPPES Provider LastName | FESSLER | |
| NPPES Provider FirstName | BARRI | |
| NPPES Provider ZIPCode | 35233 | |
| NPPES Provider State | AL | |
| Specialty Description | Rheumatology | |
| Total Claim Count | 1441.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 145.0 | |
| Percent Opioid Claims | 10.06 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1164466835 |
| Last Name Of The Provider | FESSLER |
| First Name Of The Provider | BARRI |
| View All |
Similar Doctors
|
|
Dr. Angelo L. Gaffo Llontop, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John D. Mountz Sr., MD |
|
|
Dr. Iris Y. Navarro-Millan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kenneth G. Saag, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Joel D. Abbott, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jasvinder Singh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew B. Mullen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Laura B. Hughes, MD
This Doctor is OpenDoctor Recommended.
|